Animal health company Zoetis and Neogen Corporation, a food and animal safety solution provider, have entered into a definitive acquisition agreement. Under the $160 million deal, Zoetis will acquire ...
In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial populations, fragmented global expectations, and production bottlenecks as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results